MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    A Machine Learning-Based Approach to Identify Responders to Electrosonic Brain Stimulation in Parkinson’s Disease

    L. Dipietro, U. Eden, S. Elkin-Frankston, M. El-Hagrassy, D. Doruk Camsari, C. Ramos-Estebanez, F. Fregni, T. Wagner (Cambridge, USA)

    Objective: To determine whether baseline motor phenotyping with the Integrated Motion Analysis Suite (IMAS), a multimodal sensor-based assessment platform, can identify clinically meaningful Parkinson’s disease…
  • 2026 International Congress

    Predicting Dementia in Parkinson’s Disease Using Blood-Based Proteomics

    R. Real, Y. Kordovska, O. Swann, A. Nodehi, Y. Ben-Shlomo, N. Williams, D. Grosset, J. Hardy, A. Heslegrave, H. Zetterberg, H. Morris (London, United Kingdom)

    Objective: To identify a proteomic profile associated with the future development of dementia in recently diagnosed Parkinson’s disease (PD) patients. Background: Dementia is a common…
  • 2026 International Congress

    Neuroimaging-guided automated optimization of deep brain stimulation in Parkinson’s disease: preliminary results

    G. Imbalzano, C. Ledda, A. Romagnolo, M. Rizzone, L. Lopiano, M. Zibetti (Turin, Italy)

    Objective: To evaluate the clinical impact of an automated neuroimaging-guided optimization algorithm (Illumina™, Boston Scientific) for programming in patients with suboptimal response to subthalamic nucleus…
  • 2026 International Congress

    Tardive Dystonia Case Ceries and Choreathethosis Case Report Secondary to Cocaine Use From a Specialized Movement Disorder Center in Santiago, Chile.

    M. Niedbalski, M. Canals, F. Urbina, V. Besa (Santiago, Chile)

    Objective: To describe a series of patients with tardive dystonia and a single case with choreoathethosic movements, with cocaine consumption and without an identified secondary…
  • 2026 International Congress

    Weight and Body Mass Index Changes in Parkinson’s Disease and Their Association with Disease Progression: A Two-Year Longitudinal Study

    NF. Rahmy, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: To analyze disease progression in relation to changes in body weight (BW) and body mass index (BMI) over two years in Parkinson’s disease (PD)…
  • 2026 International Congress

    Association of Benign Prostatic Hyperplasia With Incident Parkinson’s Disease in Men: A Prospective Cohort Study From the UK Biobank

    Y. Yu, X. Zheng, Y. Wang, X. Liu, H. Shang, C. Li (Chengdu, China)

    Objective: To evaluate whether benign prostatic hyperplasia (BPH) is associated with incident Parkinson’s disease (PD) in men and to explore whether BPH-related medications may influence…
  • 2026 International Congress

    Multimodal Information Exploration for Automated Clinical Scale Prediction in Neurodegenerative Diseases

    N. Bozetine, M. Wójcik-Pędziwiatr, M. Baran, J. Stępień, J. Krzywdziak, W. Szecówka, M. żbik, M. Dudek, J. Sikora, D. Hemmerling, M. Rudzińska-Bar (Warsow, Poland)

    Objective: The primary objective of this study was to develop and evaluate machine learning methods for the automatic prediction of standardized clinical scales using multimodal…
  • 2026 International Congress

    A Case of Anti-NMDA Receptor Encephalitis Presenting with Refractory Myoclonus and Perioral Dyskinesia during the First Trimester of Pregnancy

    TK. Yoon, SY. You (Seoul, Republic of Korea)

    Objective: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an autoimmune disorder often presenting with psychiatric symptoms, seizures, and characteristic movement disorders such as orofacial dyskinesia. Its occurrence…
  • 2026 International Congress

    Multimodal Quantitative MRI Improves Parkinson’s Disease Classification

    P. González-Méndez, N. Castillo-Triana, C. Juri, M. Andia (Santiago, Chile)

    Objective: To evaluate multimodal MRI discrimination of Parkinson’s disease using RPCA–kNN and associations with MDS-UPDRS. Background: Parkinson’s disease (PD) involves progressive neurodegeneration affecting basal ganglia…
  • 2026 International Congress

    The Effects of Bright Light Therapy on Improving Sleep Disorders in Parkinson’s Disease

    WY. Xie, JM. Duan, WX. Duan, Y. Chen, F. Wang, Y. Shen, CF. Liu (Suzhou, China)

    Objective: To explore the effects of bright light therapy (BLT) on improving sleep disorders in Parkinson‘s disease (PD). Background: Sleep disorders are common clinical symptoms…
  • « Previous Page
  • 1
  • …
  • 150
  • 151
  • 152
  • 153
  • 154
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley